Fulgent Genetics, Inc. FLGT.MX Stock
Fulgent Genetics, Inc. Price Chart
Fulgent Genetics, Inc. FLGT.MX Financial and Trading Overview
Fulgent Genetics, Inc. stock price | 360.75 MXN |
Previous Close | 663.26 MXN |
Open | 0 MXN |
Bid | 0 MXN x N/A |
Ask | 0 MXN x N/A |
Day's Range | 716.5 - 716.5 MXN |
52 Week Range | 555 - 1171.65 MXN |
Volume | 0 MXN |
Avg. Volume | 2 MXN |
Market Cap | 19.08B MXN |
Beta (5Y Monthly) | 1.545422 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -92.66 MXN |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
FLGT.MX Valuation Measures
Enterprise Value | 20.82B MXN |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 52.28895 |
Price/Book (mrq) | 15.083949 |
Enterprise Value/Revenue | 57.051 |
Enterprise Value/EBITDA | -12723.872 |
Trading Information
Fulgent Genetics, Inc. Stock Price History
Beta (5Y Monthly) | 1.545422 |
52-Week Change | -27.77% |
S&P500 52-Week Change | 20.43% |
52 Week High | 1171.65 MXN |
52 Week Low | 555 MXN |
50-Day Moving Average | 617.17 MXN |
200-Day Moving Average | 662.05 MXN |
FLGT.MX Share Statistics
Avg. Volume (3 month) | 2 MXN |
Avg. Daily Volume (10-Days) | 0 MXN |
Shares Outstanding | 29.7M |
Float | 20.3M |
Short Ratio | N/A |
% Held by Insiders | 31.80% |
% Held by Institutions | 45.32% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -7.10% |
Operating Margin (ttm) | -9.85% |
Gross Margin | 39.23% |
EBITDA Margin | -0.44% |
Management Effectiveness
Return on Assets (ttm) | -1.58% |
Return on Equity (ttm) | -2.12% |
Income Statement
Revenue (ttm) | 364.87M MXN |
Revenue Per Share (ttm) | 12.19 MXN |
Quarterly Revenue Growth (yoy) | -79.29% |
Gross Profit (ttm) | 366.9M MXN |
EBITDA | -1636000 MXN |
Net Income Avi to Common (ttm) | -25916000 MXN |
Diluted EPS (ttm) | -14.76 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 504.48M MXN |
Total Cash Per Share (mrq) | 16.99 MXN |
Total Debt (mrq) | 35.33M MXN |
Total Debt/Equity (mrq) | 2.78 MXN |
Current Ratio (mrq) | 7.087 |
Book Value Per Share (mrq) | 42.585 |
Cash Flow Statement
Operating Cash Flow (ttm) | 57.2M MXN |
Levered Free Cash Flow (ttm) | 72.18M MXN |
Profile of Fulgent Genetics, Inc.
Country | Mexico |
State | CA |
City | Temple City |
Address | 4978 Santa Anita Avenue |
ZIP | 91780 |
Phone | 626 350 0537 |
Website | https://www.fulgentgenetics.com |
Industry | Diagnostics & Research |
Sector(s) | Healthcare |
Full Time Employees | 1012 |
Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and next generation sequencer services related to hereditary cancer, cardiovascular genetics, reproductive health, and neurodegenerative genetics, as well as pharmacogenetic tests. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a novel nanoencapsulation and targeted therapy platform designed to enhance the therapeutic window and pharmacokinetic profile, or PK profile, of new and existing cancer drugs. The company also operates picture genetics platform which includes proprietary gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California.
Q&A For Fulgent Genetics, Inc. Stock
What is a current FLGT.MX stock price?
Fulgent Genetics, Inc. FLGT.MX stock price today per share is 360.75 MXN.
How to purchase Fulgent Genetics, Inc. stock?
You can buy FLGT.MX shares on the Mexico exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Fulgent Genetics, Inc.?
The stock symbol or ticker of Fulgent Genetics, Inc. is FLGT.MX.
Which industry does the Fulgent Genetics, Inc. company belong to?
The Fulgent Genetics, Inc. industry is Diagnostics & Research.
How many shares does Fulgent Genetics, Inc. have in circulation?
The max supply of Fulgent Genetics, Inc. shares is 29.9M.
What is Fulgent Genetics, Inc. Price to Earnings Ratio (PE Ratio)?
Fulgent Genetics, Inc. PE Ratio is now.
What was Fulgent Genetics, Inc. earnings per share over the trailing 12 months (TTM)?
Fulgent Genetics, Inc. EPS is -92.66 MXN over the trailing 12 months.
Which sector does the Fulgent Genetics, Inc. company belong to?
The Fulgent Genetics, Inc. sector is Healthcare.